Navigation Links
AggRAM Analyzer

ProductsAggRAM Analyzer
Company Helena Laboratories
Item AggRAM Analyzer
Features 
  • 4 or 8 Channels
  • Powerful Data Handling
  • Customized Reports
  • Quality Control
Description AggRAM, for platelet aggregation and ristocetin cofactor testing, couples a four-channel analyzer with the power of Windows-based software for unsurpassed testing flexibility. Up to two AggRAM modules can be run on one Remote Analyzer Module computer so you can configure your analyzers to suite your testing needs.
Info Helena Laboratories
Customer Service: (800) 231-5663
Web site: http://www.helena.com/

Related medicine products :

1. Pachymetric Analyzer Model 55
2. Humphrey Field Analyzer II - i series
3. OPD-Scan Refractive Power / Corneal Analyzer
4. OPD-Scan II Refractive Power / Corneal Analyzer
5. Coulter LH 750 Hematology Analyzer
6. Express Plus Clinical Chemistry Analyzer
7. Roche OMNI C Blood Gas Analyzer
8. RapidLab 248 Blood Gas Analyzer
9. Rapidlab 348 Blood Gas Analyzer
10. ABL77 Blood Gas Analyzer
11. COULTER LH 750 Hematology Analyzer
Other Medicine News:Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3Health News:First Boston Pharma, LLC Acquires NutraMax Products, Inc. 2Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 2Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 3Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 4Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2Testosterone Therapy May Help Men With Heart Failure 55194 1Testosterone Therapy May Help Men With Heart Failure 55194 2Testosterone Therapy May Help Men With Heart Failure 55194 3